| Closed |
SWOG-229 |
Study of Dibromomannitol in Chronic Granulocytic Leukemia |
8/6/1969 |
|
1% |
|
|
| Closed |
SWOG-8302 |
Study of Doxorubicin, Mitomycin-C and 5-Fluorouracil in the Treatment of Metastatic Adenocarcinoma of the Prostate |
7/26/1983 |
8/17/1984 |
|
|
Published
|
| Closed |
SWOG-9016 |
Study of External Brain Irradiation and Cisplatin/BCNU Followed by BCNU For The Treatment of Primary Malignant Brain Tumors |
7/15/1991 |
7/1/1992 |
100% |
|
Published
|
| Closed |
SWOG-7956 |
Study of Postinfarction Nephrectomy and Medroxy- progesterone Acetate (Depo-Provera) in Metastatic Renal Cell Carcinoma |
2/9/1980 |
1/19/1984 |
|
|
Published
|
| Closed |
SWOG-7716 |
Study of Tamoxifen in Metastatic Renal Cell Carcinoma |
12/29/1977 |
12/28/1978 |
|
|
|
| Closed |
SWOG-9137 |
Study of the Safety and Efficacy of Photodynamic Therapy Using Photofrin® (Porfimer Sodium) in the Therapeutic and Prophylactic Management of Transitional Cell Carcinoma of the Bladder |
3/15/1992 |
12/1/1993 |
4% |
|
|
| Closed |
SWOG-9133 |
Subtotal Nodal Irradiation vs Doxorubicin+Vinblastine+Subtotal Nodal Irradiation |
9/15/1992 |
4/24/2000 |
75% |
|
Published
|
| Closed |
S0337 |
Superficial Bladder, Post-TURBT Gemcitabine vs Saline, Ph III |
7/15/2007 |
8/15/2012 |
100% |
|
|
| Closed |
S9709 |
Supraglottic Larynx |
9/15/1997 |
12/1/2001 |
65% |
|
Published
|
| Closed |
S1316 |
Surgery vs Non-Surgical Management for MBO |
3/9/2015 |
|
100% |
|
|
| Closed |
S9900 |
Surgery vs. Surgery/Preop Pac/Carbo in NSCLC; IB, II & selected IIIA |
10/15/1999 |
7/15/2004 |
53% |
|
Published
|
| Closed |
SWOG-9430 |
Surgical Resection for Stage IV Melanoma |
11/15/1996 |
11/15/2005 |
70% |
|
Published
|
| Closed |
S2011 |
SWOG GAPTrial |
10/6/2021 |
11/15/2023 |
3% |
|
|
| Closed |
S0346 |
Synovial |
7/15/2005 |
12/1/2006 |
0% |
|
|
| Closed |
S1607 |
T-VEC + Pembro in Adv Melanoma follow prog on PD-1 Inhibitor |
10/2/2017 |
11/1/2020 |
67% |
|
|
| Closed |
S9805 |
Tandem transplant in WM |
9/1/1998 |
5/1/2000 |
18% |
|
|
| Open |
S2210 |
Targeted Neoadjuvant Treatment for Patients with Localized Prostate Cancer and Germline DNA Repair Deficiency |
8/14/2023 |
|
7% |
|
|
| Open |
S1900K |
Targeted Treatment for Advanced NSCLC that has a MET Exon 14 Skipping Gene Change |
12/18/2023 |
|
4% |
|
|
| Open |
S1900J |
Targeted Treatment for Advanced NSCLC with High MET-Amplification |
9/27/2024 |
|
1% |
|
|
| Closed |
S9714 |
Taxol in Stage IIIB & IV BAC |
5/15/1997 |
3/15/2000 |
100% |
|
Published
|
